Literature DB >> 30086267

GSH depletion, mitochondrial membrane breakdown, caspase-3/7 activation and DNA fragmentation in U87MG glioblastoma cells: New insight into the mechanism of cytotoxicity induced by fluoroquinolones.

Artur Beberok1, Zuzanna Rzepka2, Michalina Respondek2, Jakub Rok2, Daniel Sierotowicz2, Dorota Wrześniok2.   

Abstract

Fluoroquinolones are a known synthetic group of antibiotics that have been the subject of many research interests. This class of antibiotics was shown to be cytotoxic towards various cancer cell lines, thus representing a potentially important source of new anticancer agents. The present study was designed to examine the effect of ciprofloxacin and moxifloxacin on cell viability, redox balance and apoptosis in U87MG glioblastoma cells. Herein, we found that both fluoroquinolones decrease the viability and exert an anti-proliferative effect on U87MG cells. The EC50 values were found to be as 0.75 µmol/ml, 0.57 µmol/ml, 0.53 µmol/ml for ciprofloxacin and 24, 48, 72 h incubation time, respectively, and 0.48 µmol/ml, 0.22 µmol/ml, 0.15 µmol/ml for moxifloxacin and 24, 48, 72 h incubation time, respectively. Ciprofloxacin and moxifloxacin have also induced the intracellular GSH depletion and apoptosis as shown by externalization of phosphatidylserine, caspase-3/7 activation, S and sub-G1 cell cycle arrest, nuclear morphological changes induction and DNA fragmentation. The mechanism of apoptosis was related to the loss of mitochondrial membrane potential suggesting activation of the intrinsic mitochondrial pathway. This is the first study that may provide the basis for understanding potential cellular and molecular mechanism underlying ciprofloxacin and moxifloxacin cytotoxic and pro-apoptotic effect towards U87MG glioblastoma cells, suggesting that these fluoroquinolone derivatives may have value for the development as anti-glioma agents.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Apoptosis; Ciprofloxacin; DNA fragmentation; GSH depletion; Glioblastoma multiforme; Moxifloxacin

Mesh:

Substances:

Year:  2018        PMID: 30086267     DOI: 10.1016/j.ejphar.2018.08.002

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  5 in total

1.  Interaction between moxifloxacin and Mcl-1 and MITF proteins: the effect on growth inhibition and apoptosis in MDA-MB-231 human triple-negative breast cancer cells.

Authors:  Artur Beberok; Jakub Rok; Zuzanna Rzepka; Krzysztof Marciniec; Stanisław Boryczka; Dorota Wrześniok
Journal:  Pharmacol Rep       Date:  2022-09-01       Impact factor: 3.919

2.  Potential adverse effects of ciprofloxacin and tetracycline on ARPE-19 cell lines.

Authors:  Nasim Salimiaghdam; Lata Singh; Kevin Schneider; Angele Nalbandian; Marilyn Chwa; Shari R Atilano; Andrea Bao; M Cristina Kenney
Journal:  BMJ Open Ophthalmol       Date:  2020-07-21

3.  Design, Synthesis, and Structural Characterization of Novel Diazaphenothiazines with 1,2,3-Triazole Substituents as Promising Antiproliferative Agents.

Authors:  Beata Morak-Młodawska; Krystian Pluta; Małgorzata Latocha; Małgorzata Jeleń; Dariusz Kuśmierz
Journal:  Molecules       Date:  2019-11-30       Impact factor: 4.411

4.  UVA Radiation Enhances Lomefloxacin-Mediated Cytotoxic, Growth-Inhibitory and Pro-Apoptotic Effect in Human Melanoma Cells through Excessive Reactive Oxygen Species Generation.

Authors:  Artur Beberok; Zuzanna Rzepka; Jakub Rok; Klaudia Banach; Dorota Wrześniok
Journal:  Int J Mol Sci       Date:  2020-11-25       Impact factor: 5.923

Review 5.  Biological Effects of Quinolones: A Family of Broad-Spectrum Antimicrobial Agents.

Authors:  Ana R Millanao; Aracely Y Mora; Nicolás A Villagra; Sergio A Bucarey; Alejandro A Hidalgo
Journal:  Molecules       Date:  2021-11-25       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.